VERAH BONARERI: Open Payments
NPI 1588309124 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$730 in 24 payments from 13 companies in 2025. Trend: 2023 $523 · 2024 $927 · 2025 $730
Food & beverage: $730
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $206 |
| Novartis Pharmaceuticals Corporation | 1 | $89 |
| CVRx, Inc. | 1 | $81 |
| Merck Sharp & Dohme LLC | 4 | $78 |
| Kestra Medical Technology Services, Inc. | 3 | $56 |
| Novo Nordisk Inc | 2 | $42 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $38 |
| Resmed Corp | 1 | $34 |
| Corcept Therapeutics | 1 | $31 |
| Amgen Inc. | 1 | $22 |
Products named: Kerendia, LEQVIO, Barostim Neo System, VERQUVO, Assure WCD, Adempas, LifeVest, AIRSENSE.
Industry payments across MO — which companies pay providers there.
